Search

everythinglearnresearchcommunity

for

Search:↓

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Avacopan may cause unexpected side effects, so early monitoring is important.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Tofacitinib helped a woman regrow hair with no major side effects.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Semaglutide may worsen eating disorders in vulnerable individuals.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Gefitinib therapy can cause unusual hair growth on the nose.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Tofacitinib, a hair regrowth treatment, may worsen acne.